Emerging biotech firms, top pharma rely on Veeva Link for client interaction and data-driven AI initiatives.
ByAinvest
Wednesday, Feb 4, 2026 10:00 am ET1min read
VEEV--
Veeva Systems has announced that 13 of the top 20 biopharmaceutical companies have standardized on Veeva Link Key People to improve customer interaction and provide data for AI initiatives globally. 38 new clients have been added, with three of the top 20 biopharmaceutical companies adopting it as their global standard in the last year. The move is expected to enhance data-driven decision-making, improve segmentation accuracy, and foster more engaging interactions with healthcare professionals.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet